- News Home
10 April 2014 11:44 am ,
Vol. 344 ,
The Pyrenean ibex, an impressive mountain goat that lived in the central Pyrenees in Spain, went extinct in 2000. But a...
Tight budgets are forcing NASA to consider turning off one or more planetary science projects that have completed their...
Ebola is not a stranger to West Africa—an outbreak in the 1990s killed chimpanzees and sickened one researcher. But the...
In an as-yet-unpublished report, an international panel of geoscientists has concluded that a pair of deadly...
Tropical disease experts tried and failed before to eradicate yaws, a rare disfiguring disease of poor countries. Now,...
Since 2002, researchers have reported that agricultural communities in the hot and humid Pacific Coast of Central...
Balkan endemic kidney disease surfaced in the 1950s and for decades defied attempts to finger the cause. It occurred...
- 10 April 2014 11:44 am , Vol. 344 , #6180
- About Us
Gene Synthesis Companies Pledge to Foil Bioterrorists
19 November 2009 6:06 pm
Advances in synthetic biology have prompted fears that terrorists might develop biological weapons by purchasing made-to-order DNA sequences from gene synthesis companies and using them to engineer deadly pathogens. Five of the world's leading gene synthesis companies today announced steps they are already implementing—or plan to implement—a plan to prevent misuse of the technology. The announcement comes amid calls for tougher government controls on the field of synthetic genomics.
The companies, which make up what they call the International Gene Synthesis Consortium, already examine purchase orders to ensure that they are not supplying customers with genomes of pathogens that many governments consider as potential threats to biosecurity. The consortium's members now plan to strengthen this procedure by screening orders against a database they say will be more comprehensive.
In addition, the companies have committed to screening clients to confirm their identities and ensure that the clients are permitted by their governments to possess the sequences they've requested. And the companies will keep all records of orders, screenings, and deliveries for at least 8 years to assist law enforcement if necessary.
"Gene synthesis itself provides us with powerful new opportunities to combat the threat of bioterrorism," Jeremy Minshull, president of DNA2.0—a consortium member, said in a press release. "We won't tolerate attempts to misuse gene synthesis technology to threaten the safety of any community."